A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 48,900 shares of CLPT stock, worth $768,219. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,900
Previous 169,700 71.18%
Holding current value
$768,219
Previous $914,000 40.04%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$5.3 - $13.18 $640,240 - $1.59 Million
-120,800 Reduced 71.18%
48,900 $548,000
Q2 2024

Aug 09, 2024

BUY
$5.25 - $6.73 $756,462 - $969,712
144,088 Added 562.58%
169,700 $914,000
Q1 2024

May 13, 2024

BUY
$6.03 - $7.86 $154,440 - $201,310
25,612 New
25,612 $174,000
Q4 2022

Feb 13, 2023

BUY
$7.7 - $11.21 $379,894 - $553,067
49,337 New
49,337 $418,000
Q2 2022

Aug 12, 2022

SELL
$7.09 - $13.65 $1.1 Million - $2.12 Million
-155,000 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$7.8 - $11.6 $560,040 - $832,880
71,800 Added 86.3%
155,000 $1.61 Million
Q4 2021

Feb 11, 2022

BUY
$11.08 - $18.86 $921,856 - $1.57 Million
83,200 New
83,200 $934,000
Q3 2021

Nov 12, 2021

SELL
$16.58 - $22.25 $790,865 - $1.06 Million
-47,700 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$17.23 - $22.77 $480,717 - $635,283
-27,900 Reduced 36.9%
47,700 $911,000
Q1 2021

May 13, 2021

BUY
$15.19 - $29.0 $342,564 - $654,008
22,552 Added 42.51%
75,600 $1.6 Million
Q4 2020

Feb 10, 2021

BUY
$5.11 - $15.89 $56,721 - $176,379
11,100 Added 26.46%
53,048 $843,000
Q3 2020

Nov 13, 2020

SELL
$3.19 - $5.89 $27,599 - $50,960
-8,652 Reduced 17.1%
41,948 $229,000
Q2 2020

Aug 13, 2020

BUY
$3.08 - $4.56 $68,684 - $101,687
22,300 Added 78.8%
50,600 $180,000
Q1 2020

May 14, 2020

BUY
$3.33 - $6.14 $94,239 - $173,762
28,300 New
28,300 $101,000

Others Institutions Holding CLPT

About ClearPoint Neuro, Inc.


  • Ticker CLPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,488,300
  • Market Cap $385M
  • Description
  • ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...
More about CLPT
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.